Both ordinary resolutions sail through with over 99.6% votes in favour, strengthening leadership continuity at the drugmaker
36 districts to get advanced ALS, BLS and neonatal ambulances under MEMS 108
Final approval for progesterone vaginal inserts expands Glenmark’s women’s healthcare portfolio in the US, targeting a market of over $59 million
Surgeon Yuvaraja operates on a 55-year-old patient at Medical City Hospital Muscat
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
Backed by a £680,000 grant from Leeds Hospitals Charity, the study is jointly led by academics and clinicians from the University of Leeds and Leeds Teaching Hospitals NHS Trust
The acquisition complements Gilead’s existing oncology expertise and development infrastructure
In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga
The deal gives Vertex access to Halozyme’s Hypercon technology for up to three drug targets
The results were consistent across both the 10 mg and 40 mg treatment arms
Subscribe To Our Newsletter & Stay Updated
